52 / 80
E. Martín Gutiérrez
et al.
/ Cir Cardiov. 2016;
23(1)
:31–37
37
DTA
frente a
la monoterapia
con AAS en el postoperatorio de CDC,
así
como para determinar
su prescripción óptima. En
el momento
actual,
la
individualización
de
la
terapia
antiagregante
debe
ser
una práctica homogeneizada
institucionalmente de acuerdo con el
mejor balance
riesgo/beneficio de
cada práctica
clínica particular.
Conflicto de
intereses
Los autores declaran no
tener ningún
conflicto de
intereses.
Bibliografía
1.
Reaume KT, Regal RE, Dorsch MP. Indications for dualantiplatelet therapy with aspirin and clopidogrel: Evidence-based recommendations for use. Ann Phar- macother. 2008;42:550 –7.
2.
Ca ˜nivano Petre ˜nas L, Garcıa Yuberob C. Resistencia a la aspirina: prevalencia, mecanismos de acción y asociación con eventos tromboembólicos. Revisión narrativa.Farm Hosp.
2010;34(1):32
–
43.3.
Hurst NL, Nooney VB, Raman B, Chirkov YY, de Caterina R, Horowitz JD. Clo- pidogrel “resistance”: Pre- vs post-receptor determinants. Vascul Pharmacol. 2013;59(5-6):152 –61.4.
Muller I, SeyfrathM, Rüdinger S, Wolf B, Pogatsa-Murray G, Schömig A, et al. Clopidogrel is higher dose better? Heart. 2001;85:92 –3.
5.
Wang X, GongX, Zhu T, Zhang
Q,
Zhang Y, Wang X, et al. Clopidogrel improves aspirin response after off-pump coronary artery bypass surgery. J
Biomed Res. 2014;28(2):108– 13.
6.
Kim DH, Daskalakis C, Silvestry SC, Sheth MP, Lee AN, Adams S, et al. Aspi- rin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2009;138(6):1377 –84.7.
Sorensen R, Abildstrom SZ, Hansen PR, Hvelplund A, Andersson C, Charlot M, et al. Efficacy of post-operative clopidogrel treatment in patients revasculari- zed with coronary artery bypass grafting after myocardial infarction. J Am Coll Cardiol.2011;57(10):1202 –9.
8.
Shukla N, Jeremy JY. Pathophysiology of saphenous vein graft failure: A brief overviewof interventions. Curr Opin
Pharmacol. 2012;12(2):114 –20.
9.
Herbert JM, Tissinier A, Defreyn G, Maffrand JP. Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits. Arterioscler Thromb. 1993;13(8):1171 –9.10.
Kulik A, le May MR, VoisineP, Tardif JC, Delarochelliere R, Naidoo S, et al. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: The clopidogrel after surgery for coronary artery disease (CASCADE) Trial. Circula- tion. 2010;122(25):2680 –7.
11.
UneD, Al-Atassi T, Kulik A, Voisine P, le
May M, Ruel M. Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery. Circulation. 2014;130:S12– 8.
12.
Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al., Ameri- can College of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: A report of the American
College of Cardio- logy Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac
Cardiovasc Surg. 2012;143(1):4 –34.
13.
Kolh P, Windecker
S, Alfonso
F, Collet
JP, Cremer
J,
Falk V,
et
al.; EACTS Clinical
Guidelines Committee; Task Force on Myocardial Revascularization of
the Euro-
pean
Society
of
Cardiology
and
the
European
Association
for
Cardio-Thoracic
Surgery;
European
Association
of
Percutaneous
Cardiovascular
Interventions.
2014
ESC/EACTS
Guidelines
on myocardial
revascularization:
The
Task
Force
on Myocardial
Revascularization
of
the
European
Society
of
Cardiology
(ESC)
and
the
European
Association
for
Cardio-Thoracic
Surgery
(EACTS).
Develo-
ped with
the
special
contribution of
the European Association of Percutaneous
Cardiovascular
Interventions
(EAPCI).
Eur
J
Cardiothorac
Surg.
2014;
46(4):
517-592.
14.
Sun JC, Teoh KH, Lamy A, Sheth T, Ellins ML, Jung H, et al. Randomized trial of aspirin andclopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: The Preoperative Aspirin and
Postoperative Antiplatelets in
Coronary Artery
Bypass Grafting study. Am Heart J. 2010;160(6):1178
–
84.15.
Gasparovic H,Petricevic M, Kopjar T, Djuric Z,
Svetina L, Biocina B. Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting. Am J
Cardiol.
2014;113(10):1660 –7.
16.
Ebrahimi R, Bakaeen FG,Uberoi A, Ardehali A, Baltz JH, Hattler B, et al. Effect of clopidogrel use post coronary artery bypass surgery on graft patency. Ann Thorac
Surg.
2014;97(1):15– 21.
17.
Fitchett D, Eikelboom J, Fremes S, Mazer D, Singh S, Bittira B, et al.Dual anti- platelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society. Can J Cardiol. 2009;25(12):683
–
9.18.
GaoG, Zheng Z, Pi Y, Lu
B, Lu J, Hu S. Aspirin plus clopidogrel therapy increases early venous graft patency
after coronary
artery bypass surgery. A single-center, randomized, controlled trial. J Am
Coll Cardiol. 2010;56(20):1639– 43.
19.
Mannacio VA, di Tommaso L, Antignan A, de Amicis V, Vosa C. Aspirin plus clopidogrel for optimalplatelet inhibition following off-pump coronary artery bypass surgery: Results
from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study. Heart. 2012;98(23): 1710 –5.
20.
Mujanovic E, Nurkic M,Caluk J, Terzic I,
Kabil E, Bergsland J. The effect of com- bined clopidogrel and aspirin therapy after
off-pump coronary surgery: A pilot study. Innovations (Phila). 2009;4(5):265 –8.
21.
Engoren M, Hadaway J,Schwann TA, Habib RH. Ketorolac improves graft patency after coronary artery bypass grafting: A propensity-matched analysis. Ann Tho- rac Surg. 2011;92(2):603 –9.
22.
Ibrahim K, Tjomsland O, Halvorsen D, Wiseth R, Wahba A, Karevoid A, et al. Effect of clopidogrel on midterm graft patency following off-pump coronary revascularization surgery. J Am CollCardiol.
2010;56(20):1639 –43.
23.
Shenibb H, Endo M, Benhameid O. A feasibility study of the safety and efficacy of a combined clopidogrel and aspirin regimen following off-pump coronary artery bypassgrafting. Heart
Surg Forum. 2003;6(5):288 –91.
24.
Gurbuz AT, Zia AA, Vuran AC, Cui H, Aytac A. Postoperative clopidogrel impro- ves mid-term outcome after off-pump coronary artery bypass graft surgery: A prospective study.Eur J Cardiothorac Surg. 2006;29(2):190 –5.
25.
Kayacioglu I, Gunay R, Saskin H, Idiz M, Sensoz Y, Ates M,et al. The role
of clopi- dogrel and acetylsalicylic acid in the prevention of early-phase graft occlusion due to reactive thrombocytosis after coronary artery bypass operation.
Heart Surg
Forum.
2008;11(3):E152 –7.
26.
Nocerino AG, Achenbach S, Taylor AJ.Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary
bypass grafting. Am J Cardiol. 2013;112(10):1576 –9.
27.
Deo SV, Dunlay SM, Shah IK, Altarabsheh SE, Erwin PJ, Boilson BA, et al. Dual anti-platelet therapy after coronaryartery bypass grafting: Is there any benefit? A systematic review and meta-analysis. J
Card
Surg. 2013;28(2):109
–
16.28.
De LeonN, Jackevicius CA. Use of aspirin and clopidogrel after coronary artery bypass graft surgery. Ann Pharmacother. 2012;46(5):678 –87.
29.
Wang Z, Gao F, Men J, Ren J, Modi P, Wei M. Aspirin resistance in off-pump coronary artery bypass grafting.Eur J
Cardiothorac
Surg.
2012;41(1):108– 12.